Diana in the News

Rep. Diana DeGette (D-Colo.), who introduced the House proposal for new research aid, called the challenges for research universities a “crisis.” “Aside from studies being shut down, researchers themselves are at risk of losing their jobs,” she said. “The impact on younger researchers and graduate students could have a wave effect.” If additional research funding can’t be included in a comprehensive Covid package before the November elections, DeGette said she would push to pass legislation during the lame-duck session.

The idea for the commission was largely developed and added by Sen. Cory Gardner (R-Colo.) and Rep. Diana DeGette (D-Colo.).

Colorado Rep. Diana DeGette chaired a House of Representatives Energy and Commerce Oversight and Investigations Subcommittee panel to hear how coronavirus vaccines should be evaluated for safety.

Over the years, there have been numerous challenges in the way the United States has approached reproductive health. We rely on our public health institutions to make decisions using the best data to get the best outcomes. Twenty years ago, the Food and Drug Administration (FDA) approved mifepristone, the pill for medication abortion with numerous restrictions on who could prescribe the medication, where it could be taken and where it could be dispensed.